27/01/2026
Health insurer shares slide after CMS proposes nearly flat 2027 Medicare Advantage rate update
UnitedHealth, Humana, CVS and other insurers fell after the Trump administration proposed a 0.09% average increase in Medicare Advantage payment rates for 2027, far below what analysts expected.
- Published
- Revised

Shares of several major U.S. health insurers dropped on January 27, 2026 after the Centers for Medicare & Medicaid Services released a proposed update that would raise Medicare Advantage payment rates by an average of just 0.09% in 2027. The proposal, widely seen as a major downside surprise versus Wall Street expectations for a much larger increase, immediately pressured stocks across the managed-care space. ([ft.com](https://www.ft.com/content/cd12e11b-6bae-4238-8fc8-e93944578f6f?utm_source=openai))

The Medicare Advantage market is large and still growing, covering tens of millions of older Americans and people with disabilities through private plans paid largely by the federal government. Because insurer profitability is tightly linked to reimbursement trends and medical-cost inflation, even a modest change in the expected rate path can reprice earnings outlooks quickly. ([ft.com](https://www.ft.com/content/cd12e11b-6bae-4238-8fc8-e93944578f6f?utm_source=openai))
What’s in the proposal—and why it hit margins
Beyond the topline 0.09% figure, investors also focused on proposed adjustments tied to risk scoring and diagnostic coding, which could reduce payments associated with certain documentation methods. Analysts and industry groups warned the update could translate into benefit cuts, higher member costs, or plan changes if final rates do not keep pace with medical-cost trends. CMS noted the proposal can still change before it is finalized later in the year. ([investopedia.com](https://www.investopedia.com/here-is-why-health-insurance-stocks-are-sinking-tuesday-11893199?utm_source=openai))
In trading, the reaction was steepest among companies with heavy Medicare Advantage exposure. The move also reflected broader investor concerns that the administration may keep ratcheting pressure on the industry amid heightened political attention to healthcare costs and profits. ([ft.com](https://www.ft.com/content/cd12e11b-6bae-4238-8fc8-e93944578f6f?utm_source=openai))
What to watch next
- How CMS revises the proposed rate update before final publication.
- Whether insurers respond by narrowing benefits, adjusting premiums, or exiting certain counties.
- How companies describe medical-cost trends and margin plans in upcoming earnings calls.